Balloon test flight plan under fire over solar geoengineering fears

Swedish environmental groups warn test flight could be first step towards the adoption of a potentially “dangerous, unpredictable, and unmanageable” technology

A proposed scientific balloon flight in northern Sweden has attracted opposition from environmental groups over fears it could lead to the use of solar geoengineering to cool the Earth and combat the climate crisis by mimicking the effect of a large volcanic eruption.

In June, a team of Harvard scientists is planning to launch a high-altitude balloon from Kiruna in Lapland to test whether it can carry equipment for a future small-scale experiment on radiation-reflecting particles in the Earth’s atmosphere.

Continue reading...

Study shows Oxford Covid vaccine has less protection against South African variant

Researchers say vaccines’ focus must shift to protecting people from hospitalisation and death

The Oxford/AstraZeneca vaccine will not stop people becoming ill if they contract the South African variant of Covid-19, researchers have confirmed, warning that vaccines’ focus needs to shift from population immunity to protecting individuals from hospitalisation and death.

The small study in 2,000 people aged 31, who are less likely to become severely ill, adds to evidence from big trials of other vaccines carried out after the variant appeared in South Africa. Trial data from the Janssen and Novavax vaccines showed efficacy in South Africa was up to 60% against the variant, substantially lower than against the original virus.

Continue reading...

When will Britain’s Covid lockdown be lifted? Three scenarios

At best, vaccines and lockdown could make life more normal by May. But at worst, a new mutation could undo any progress

Hopes are rising that Britain may soon put the worst of Covid-19 behind it. After a year in which the disease has paralysed the nation, killed more than 100,000 people, closed schools and universities, and brought the NHS to its knees, there are now signs of hope emerging.

Most optimism stems from Britain’s vaccination programme, which has resulted in the inoculation of more than 10 million people in the past two months alone, and which aims to have vaccinated the entire adult population later this year.

Continue reading...

AstraZeneca set to weather Covid in better health than rivals

The Anglo-Swedish firm already had a strong lineup of cancer drugs when vaccine success gave it a further boost

Before the pandemic, AstraZeneca was highly regarded in the business and pharmaceutical world – seen as one of the UK’s best companies. Now, thanks to Britain’s successful vaccine programme, it is a household name.

The Anglo-Swedish firm, which publishes annual results on Thursday, has sprung to prominence as maker of one of the world’s first Covid-19 vaccines, approved for use in the UK, EU and India. Inevitably, headlines have followed. AstraZeneca has been the focal point of the vaccine supply wars between the UK and the EU and has, as part of that row, faced questions over the effectiveness of the jab in the over-65s.

Continue reading...

Star buys: celebrities send meteorite prices into orbit

Elon Musk, Steven Spielberg and Nicolas Cage among those who collect rocks that can cost millions

They really are from out of this world, and the prices are astronomical. For those who have everything they need on Earth, what they now want is a little bit of space. Meteorites are attracting the attention of celebrity collectors who have pushed the price of the rocks – which have hurtled through space for hundreds or even thousands of year before crashing into this planet – tenfold over the past decade.

More than 70 of the most spectacular meteorites ever found will go under the hammer at Christie’s auction house next week in a sale that is expected to generate millions of pounds. Included in the Deep Impact auction are meteorites embedded with gem stones and others have suffered such an impact from blasting through the atmosphere at up to 160,000mph that they resemble sculptures by Alberto Giacometti or Henry Moore.

Continue reading...

Tianwen1 probe sends back its first picture of Mars

Chinese spacecraft aiming to enter orbit in days before putting down lander and rover months later

China’s Tianwen-1 probe has sent back its first picture of Mars, the Chinese space agency has said, as the mission prepares to touch down later this year.

The spacecraft, launched in July around the same time as a US mission, is expected to enter Mars orbit around 10 February.

Continue reading...

Oxford Covid vaccine almost as effective against Kent variant, trials suggest

Scientists say it offers only slightly lower protection compared with original Covid

The Covid vaccine developed by the University of Oxford and AstraZeneca is nearly as effective against the Kent variant as it is against older forms of the virus, according to preliminary research results.

Researchers analysed swabs from trial volunteers who developed asymptomatic or symptomatic infections to determine which variant of the virus they had caught after receiving the vaccine or a control jab.

Continue reading...

‘Pandemic burnout’ on rise as latest Covid lockdowns take toll

Increasing number of people report feeling worn out and unable to cope due to period of sustained stress

Psychologists are reporting a rise in “pandemic burnout” as many people find the current phase of lockdowns harder, with an increasing number feeling worn out and unable to cope.

They warn that many are finding the latest lockdown more difficult because of a realisation that coronavirus will be around longer than expected, dashed hopes about an easing of restrictions, and a period of sustained stress similar to overwork, which has prompted symptoms such as fatigue.

Continue reading...

What are Covid variants – and should we be worried?

In the UK, all eyes are on South African, Brazilian and Kent variants - with mutations transmitting among the population

With the discovery of new coronavirus variants in parts of the UK, prompting intensive testing, we take a look at what the variants are and how concerned we should be.

Continue reading...

Coronavirus live news: variant first found in UK now accounts for 6% of German cases; Israel to ease lockdown

Germany warns new variants are set to spread; Israel to keep borders closed despite easing lockdown

Slovak regional authorities have quarantined a Roma settlement after a quarter of its residents tested positive for the coronavirus.

The settlement of Sacurov near Vranov nad Toplou in the east of the country, made up of two three-storey apartment blocks and around 70 shacks, is to be closed off for 10 days.

“In a week-and-a-half it grew [from five] to the unreal number of 113, due to a failure to maintain quarantine and isolation,” he said.

More than 80% of people in some developing countries have seen their incomes fall due to the coronavirus pandemic, economists have found, warning that rising poverty could mean poorer countries struggle to curb infections – especially with mass vaccination potentially years away.

“Economic help is part and parcel of fighting the virus,” co-author of the study Shana Warren told the Thomson Reuters Foundation.

“If you want people to stay home to stop the virus spreading while they wait for vaccines you need to provide them with the economic support to do so.”

Continue reading...

Covid: Oxford trial to test efficacy of mix of vaccines for individuals

Scientists aim to establish level of immunity in trial of 820 people, giving some a substitute vaccine at second appointment

Volunteers are being sought for a world-first trial to establish the efficacy of giving people a first dose of one vaccine and a second dose of a different vaccine.

The trial, which is being run by Oxford University and is funded by the government’s vaccine taskforce, has been described by ministers as “hugely important”.

Continue reading...

UK passes 10m Covid vaccination milestone

About 15% of population has been offered first jab, as experts call for focus on hotspots

Britain has given a first dose of a coronavirus vaccine to more than 10 million people, as public health experts call on ministers to target future vaccinations in hotspots where the disease is threatening to run out of control.

Official figures from across the UK’s four nations showed that 374,756 people received a jab on Tuesday, taking the headline total to 10.02 million, less than two months after the programme began.

Continue reading...

Israel opens coronavirus vaccines to all over-16s

New age group eligible from Thursday while focus remains on older at-risk people

Israel’s health ministry has said it will offer coronavirus vaccines to anyone over the age of 16, as part of a rapid campaign in which the majority of older and vulnerable people have already received shots.

The ministry has told healthcare providers they can start booking appointments for the new age group starting on Thursday.

Continue reading...

Up in flames: SpaceX Starship test flight ends in fiery crash, again

  • Futuristic rocket explodes on landing after test in Texas
  • Elon Musk developing Starship to carry people to Mars

SpaceX’s second full test flight of its futuristic, bullet-shaped Starship ended in another fiery crash landing on Tuesday.

Elon Musk’s company launched its latest Starship prototype from the south-eastern tip of Texas, two months after the previous test ended in an equally explosive belly flop.

Continue reading...

Sputnik V vaccine has 91.6% efficacy against symptomatic Covid, Russian trial suggests

Preliminary findings based on analysis of data from more than 20,000 participants

The Sputnik V vaccine, which has been the subject of scepticism since Russia began using it last year before trials had ended, is 91.6% effective against symptomatic Covid according to data published in one of the world’s leading medical journals.

Results in the Lancet from 20,000 trial participants suggest Sputnik’s efficacy is on a par with that of some of the leading vaccines now in use. There was good efficacy in older adults, who are at highest risk for death, but little diversity, since most participants were white males.

Continue reading...

Even with vaccines, we still need treatments for Covid. So what works?

Analysis: death rates in intensive care are falling as doctors identify more ways to help those with the disease

Vaccines may have been described as the great escape route from the Covid pandemic – but treatments, which are bringing down death rates, will be needed as much as ever in the era of jabs because the virus is not expected to go away in the foreseeable future, experts say.

“It’s going to take a long time to vaccinate the world,” said Peter Horby of Oxford University, chief investigator of the Recovery trial into Covid treatments and chair of the New and Emerging Respiratory Virus Threats Advisory Group (Nervtag). “I don’t know what the estimates are, but we’ve already seen issues with manufacturing scale-up and difficulties in delivering at scale.

Continue reading...

High infection rate makes effort to contain Covid variants even more vital

Analysis: scramble to stop spread of South African variant makes sense but may already be too late

When the coronavirus pandemic was in its infancy, one of the common silver linings scientists mentioned was the virus’s slow rate of mutation. It raised the hope that the virus lacked the agility to rapidly evolve around human immunity – whether from previous infection or vaccine. The virus is certainly slow to mutate by some standards. Sars-CoV-2 typically acquires two single letter changes in its genetic code a month, about half the rate seen in influenza.

So why are so many new variants emerging? At the heart of the problem is the fact the global pandemic is raging. Every new case is a chance for mutations to arise, spread and build up. In the simple arithmetic of evolution, when a virus mutates and gains an advantage it can rise above the others.

Continue reading...

Covid mortality down dramatically since start of pandemic

New research shows global death rates among patients in intensive care have fallen from 60% to 36%

Death rates among people who end up in intensive care with Covid-19 have improved dramatically since the start of the pandemic thanks to advances in treatment, new research has found.

The proportion of those worst affected by the disease who die from it has fallen from 60% when it first appeared early last year to 36% by October, the study of global trends shows.

Continue reading...

Tokyo Olympics: definitely going ahead unless cancelled again?

Billed as a celebration of humankind’s victory over coronavirus, Games could fall foul of pandemic for a second time

The Olympic rings have been spruced up and are once again overlooking Tokyo Bay. Countdown clocks have been reset, telling passersby there are just 171 days to go until the Tokyo 2020 Olympic Games begin.

They are supposed to build excitement in the host city and among sports fans around the world. But Japan’s Olympic dream is quickly turning sour in the face of the worst global health crisis for a century.

Continue reading...